HUE032758T2 - Regorafenibet tartalmazó bevont gyógyszerészeti készítmény - Google Patents
Regorafenibet tartalmazó bevont gyógyszerészeti készítmény Download PDFInfo
- Publication number
- HUE032758T2 HUE032758T2 HUE13762967A HUE13762967A HUE032758T2 HU E032758 T2 HUE032758 T2 HU E032758T2 HU E13762967 A HUE13762967 A HU E13762967A HU E13762967 A HUE13762967 A HU E13762967A HU E032758 T2 HUE032758 T2 HU E032758T2
- Authority
- HU
- Hungary
- Prior art keywords
- ély
- ifik
- regorafenib
- siis
- coating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (2)
1 ; kAxigv^gssxH.xrii k’v-j.ííini'íiiy, sïskdy kinidmkgdíggkllilháí, níggisfesld kkklíják íAiílsdgx iííöalldspk v<5|y lyögys;iöxdyg^ í;AgV caA poihxkxHliu, és Agskíkb ·:α\ îdpîk^xkvgigag yblgadkisiA xkgAkaíygga·, amd;s gygyvsAngsAdi kgsduygay pi>ü(vi«|^alfechOi} 4ΐ«ρ4 pidbegít és silöSí n m * \ n"\ ^ ν' ' v ' ' \ v 's ν' n s s ' ésYisssi-ï;! í;cví>né aha; a miPsliíslí a kk'viX;: x/<>k íifekSakgíipÖkttpg vásssákéé: 4^ié-f^4^¾lé?'-3·' (uélsonïisékk *' fAAälAAMpikksYAp'Xs:!!:· 14υ;Γ<\>Χ.:5!<?:4· ; (> ·,? J kis-· Hs-ké-v- '·· 0s kíl körntet s § jfm iljksí karaid i jam kiöl 4 -- 4 smstg 550x1] -1 4 k gkxsx im gí 5! }pi f sd] m é- feg HlMgm kl 4s [4 4 ] ( A-bigf - s -(u : dsOrYiCÍH ?;V:Y : Ikiubs: :Κ;5 0 rmsssy:· >· l'IsSïlïSSIS i Síérké:s· k'h:í :u>>S:i:í:d #.4s|4k(]^4-yí)r-3-(5í:|!:YnSX:í5édV:é;|k;KbS::X;4;;:5': X Π^^Γ5:ΧΥ:ν;5;·η;ν1ί:!· é'k;:;5u>'S:;í:Xlk”;:\Rl 1 Λ>· Is pgimpmS xgedii· ; kéSíiisiSísíV; ímieíg mgdrídkíidbgi kutiddsag hisikék51 yisgk4síí.
4. Ag is Ys|y 2. íséí5 yfíi>isisx«iií5d kgxgdínépy. .am-h í.skkm,:. 4. ' 's \ ' ' s ' \ t>\S'1\ls'-v'v^ s' ' s 5. A,· 1*4, glíiymsmak éáííxssiysSx aggrkid Mygdsiigdy, ahoi 0. ormi v ásd-aHsshai: skia; pidmsÁ' ágy hklygdgék p«g; vhakmkoiu::: · pakasass mrixfegssim kkkodAík spísHívésí-slköhöd pöliíiims ósAgigmi pgl(vdíd-•dk-dKg: ρ·>::Χη:Α iSAÁ pídsadgo-giikoik:! kgpXSg: kapídifíiÍXg Víígv ://vk kgXiÍi'gkií, 4. 4x ' igaoyposk •'Se:';::!; k::;--.Adism;. .éné é pdéYSsIkékiXxé! alapo isomara· íaaUx-aícs: aldKdraág pó]Kv45d-a!kAh«l} pöfímxr, ~. 4/ 5-4 igessypamek é;:nssc5yi::s \/i:n:s?: këxxgralxy, akid a peHévkíSp-pIksílípi) a kuk· pdbíggí'y ipljgy éíYiíísmiPmoggik vissiiäikaiädsiiss xrh'dï ígkikggS osooo·;. acsík-o axg jgbm, k As k-'l iggiiyphatiik bapPidyikP sggdPp k#ApTigiiy:; ahm sí bevässä mihshssa.A·:;: kigydökésk a kovptkexdksi; pidiPiddambkoh gkjpdgmgbkph sgyPbd, mlggriih ?oaim. xílík sgakgd. erén·, gdíkrmkrxifelk PkdhSdmdrm, írsíí-ss-siSíá: ;xrad-ku:d:-i. kía·, ggxíoskinscras·. ygtgimpgas:, kAggpgs pggd písgbppfíésk, vssgy eggk haveréba ’ \ > ! \ V ! <. s ' s I í ll Síé A 1, vagy 4. igggypeik xgeiTpii kgpbinPisyy riiigl g Isgydipgyr 4 idles ΡρίορίΜ rdipgiggy xoííaíköxíaívs S-dÖ 5dsiipg;kx SiiSanyAggtes vííP stka; 5 i Λk :- Uí iggiskpöiddk MdpélyÉé Pépdíik íal-sxüssbg xikgly :;as-iaj;rigk ivsyssidi-iabis ::ísX;kn;;/á SXé;4d éÎSgpkrXlëî, kl A 5 : s ' ' -. ' ' , s < sN ;iXikgysé«ídséPl!ög éifögsdMid 5i4mxét gkai s íMifik ·\%ί%$Μ%Μ pdllvdlfddrpiydpk Vmilÿsïlfî>|M>ä siispoba-cit. jVíiséksisí·-gkkcäp hklxiskilkili, hiiks^iidiakaicsdccikikv·. kίΐ·!?;:;>;tsîv;tk-Ys-iUls? sí, aédiïiiïY-k;5r::::SK:î;se;;:.<S::ssi:SS5. gl kCX5ï kikig, ::^ί::·Υ:; iks îkiulâi. «Jig 4 VÍííik-íiliUíkpí}· {, pikgA SH b áSC5S5)-í S ΧΐρίΪ-5iîks>ï;:g viiSii.sYiMS! iPpíiíkísgík ;ηΊ:gi!\.s;:s;g· gikïgllkpk siiîÎâiisîgiiiîîi!, k;irr;5gèîiï,:kiî<sx;d5k klssk, p<sbgcx:· i:-g gii-xirg-:;, kykkiggviígí, Ipfispylgk sgiígixlfpi, 'kki<>kí.;, ggíktixí. piaîiéx;, s-skguíéxi:, sgíííbíípí, kskdkg, sp&ssltBk msfeiäiöi.; eïïSî'itsi: ίΐΐίί/ίΐϊΗ,. kekpöy.L 'îMsïs^ïôt ikuPrsi.. 4rRpi4Pö:4tripL p-gűcíftífcstHí'U:; pädm^ipmplHk ;.:4:Ηχ!<·<;?!·Η vay\ ?fí-í^íiíÉs|v&gÿ èkik kg:vÿ?f4sk !3. 4 Π.. >my Ip' ípayixlnt sAÁpAi pykpiyAkx. sipoly s.ί^ΐ^ο.ΓΐίΐίΜ^-ϊδίέ'ϊ..s :ΐΐ:;5 - ί :2δ u}n:Cy4iáiíyh<in um;ürnwsn. 14,. λ : 1 :I·-· ! 3:. igpyypyylop pár;«;ίpipé syyiiyü issspijsícpv, ámspy t:Sît;pïS;Si: $x^sXáíémP<A A? f^!ivií:4yirroU<i:íiK, sí5ílyryslyΐIsíál>«s:ç«Uisîμ5:ί;S.: ; 5 A 14 iycuyi'H-Bl ••xírhh k; :;. ::??«?<·;·>, s|«é4y s p;|:QS'á|y4s|k| pká k!-.>%/k5K:S;4k^ikínur:; ykvágy mifeekHslälyos gyllylóxPssyggsí ;> /0,¾ -1 :pp Oxsk-g-x ΧίΠηΙ·^;*//;»
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12183331 | 2012-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE032758T2 true HUE032758T2 (hu) | 2017-10-30 |
Family
ID=46963450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE13762967A HUE032758T2 (hu) | 2012-09-06 | 2013-09-05 | Regorafenibet tartalmazó bevont gyógyszerészeti készítmény |
Country Status (43)
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR081060A1 (es) | 2010-04-15 | 2012-06-06 | Bayer Schering Pharma Ag | Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida |
DK3043778T3 (da) * | 2013-09-13 | 2017-11-27 | Bayer Pharma AG | Farmaceutiske sammensætninger, der indeholder refametinib |
CN104586808B (zh) * | 2014-12-27 | 2017-08-18 | 北京元延医药科技股份有限公司 | 抗肿瘤药物组合物 |
CN105136956A (zh) * | 2015-09-11 | 2015-12-09 | 江苏嘉逸医药有限公司 | 一种快速测定瑞戈非尼含量的方法 |
CN105267167A (zh) * | 2015-09-11 | 2016-01-27 | 江苏嘉逸医药有限公司 | 一种瑞戈非尼口服固体药物组合物的制备方法 |
CN106880607A (zh) * | 2015-12-15 | 2017-06-23 | 北大方正集团有限公司 | 一种含有瑞戈非尼的口腔崩解片及其制备方法 |
CN106880615A (zh) * | 2015-12-15 | 2017-06-23 | 北大方正集团有限公司 | 一种瑞戈非尼的口服固体制剂及其制备方法 |
CN105496975B (zh) * | 2015-12-17 | 2019-01-04 | 河南润弘制药股份有限公司 | 一种瑞戈非尼片剂及其制备方法 |
CN106913527A (zh) * | 2015-12-28 | 2017-07-04 | 江苏先声药业有限公司 | 一种瑞戈非尼速释微丸及其制备方法 |
CN105879049B (zh) * | 2016-05-13 | 2019-03-26 | 浙江大学 | 一种瑞戈非尼与β-环糊精的包合物及其制备方法 |
CN107661296A (zh) * | 2016-07-27 | 2018-02-06 | 江苏先声药业有限公司 | 一种瑞戈非尼固体分散体及其制备方法 |
FI3630112T3 (fi) | 2017-06-02 | 2024-05-02 | Bayer Healthcare Llc | Regorafenibin ja nivolumabin yhdistelmä syövän hoidossa |
WO2020010058A1 (en) * | 2018-07-06 | 2020-01-09 | Agios Pharmaceuticals, Inc. | Ivosidenib forms and pharmaceutical compositions |
CN111053751A (zh) * | 2018-10-16 | 2020-04-24 | 正大天晴药业集团股份有限公司 | 瑞戈非尼的缓释片剂及其制备方法 |
TWI799599B (zh) * | 2019-06-06 | 2023-04-21 | 華納國際生物科技股份有限公司 | 醫藥或保健品自乳化固體分散組成物 |
EP3861989A1 (en) | 2020-02-07 | 2021-08-11 | Bayer Aktiengesellschaft | Pharmaceutical composition containing regorafenib and a stabilizing agent |
CN112587485A (zh) * | 2021-01-08 | 2021-04-02 | 湖南南新制药股份有限公司 | 一种药物固体分散体及其制备方法 |
CN113018274A (zh) * | 2021-03-10 | 2021-06-25 | 药源生物科技(启东)有限公司 | 一种含羟丙甲纤维素的药物组合物及其制备方法 |
WO2024191389A1 (en) * | 2023-03-10 | 2024-09-19 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | A pharmaceutical composition of regorafenib |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100544717C (zh) * | 2002-09-20 | 2009-09-30 | 华生制药公司 | 含有双胍和噻唑烷二酮衍生物的药物剂型 |
CN1265793C (zh) * | 2002-11-18 | 2006-07-26 | 杭州容立医药科技有限公司 | 左西替利嗪伪麻黄碱复方口服制剂及制备方法 |
AU2004259760B9 (en) * | 2003-07-23 | 2011-02-03 | Bayer Healthcare Llc | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
MY191349A (en) * | 2004-08-27 | 2022-06-17 | Bayer Pharmaceuticals Corp | New pharmaceutical compositions for the treatment of hyper-proliferative disorders |
WO2007068381A1 (en) * | 2005-12-15 | 2007-06-21 | Bayer Healthcare Ag | Diaryl ureas for treating inflammatory skin, eye and/or ear diseases |
AR062927A1 (es) * | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
WO2008044111A1 (en) * | 2006-10-13 | 2008-04-17 | Pfizer Products Inc. | Pharmaceutical formulation tablet |
EA200970552A1 (ru) * | 2006-12-07 | 2009-10-30 | Эли Лилли Энд Компани | Изделие с празугрелом |
WO2009054550A1 (en) * | 2007-10-25 | 2009-04-30 | Bayer Yakuhin, Ltd. | Nifedipine-containing press coated tablet and method of preparing the same |
AR081060A1 (es) | 2010-04-15 | 2012-06-06 | Bayer Schering Pharma Ag | Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida |
RU2602911C2 (ru) * | 2011-05-20 | 2016-11-20 | Астразенека Юкей Лимитед | Фармацевтическая композиция, содержащая кальциевую соль розувастатина |
-
2013
- 2013-09-04 JO JOP/2013/0268A patent/JO3479B1/ar active
- 2013-09-04 UY UY0001035006A patent/UY35006A/es active IP Right Grant
- 2013-09-04 AR ARP130103145A patent/AR092439A1/es not_active Application Discontinuation
- 2013-09-05 LT LTEP13762967.1T patent/LT2892507T/lt unknown
- 2013-09-05 KR KR1020157008402A patent/KR102162036B1/ko active IP Right Grant
- 2013-09-05 MX MX2015002815A patent/MX359922B/es active IP Right Grant
- 2013-09-05 EP EP17153541.2A patent/EP3243508A1/en not_active Withdrawn
- 2013-09-05 HU HUE13762967A patent/HUE032758T2/hu unknown
- 2013-09-05 ES ES13762967.1T patent/ES2623205T3/es active Active
- 2013-09-05 CN CN201380049461.1A patent/CN104902878A/zh active Pending
- 2013-09-05 RS RS20170400A patent/RS56019B1/sr unknown
- 2013-09-05 SG SG11201501683WA patent/SG11201501683WA/en unknown
- 2013-09-05 CN CN202010052300.XA patent/CN111249247A/zh active Pending
- 2013-09-05 AU AU2013312531A patent/AU2013312531B2/en active Active
- 2013-09-05 PL PL13762967T patent/PL2892507T3/pl unknown
- 2013-09-05 CN CN202310409897.2A patent/CN116392484A/zh active Pending
- 2013-09-05 MY MYPI2015700672A patent/MY176135A/en unknown
- 2013-09-05 TW TW102131928A patent/TWI640329B/zh active
- 2013-09-05 PT PT137629671T patent/PT2892507T/pt unknown
- 2013-09-05 UA UAA201502818A patent/UA115994C2/uk unknown
- 2013-09-05 SI SI201330621T patent/SI2892507T1/sl unknown
- 2013-09-05 CA CA2883767A patent/CA2883767C/en active Active
- 2013-09-05 CN CN202310410047.4A patent/CN116392485A/zh active Pending
- 2013-09-05 CU CUP2015000020A patent/CU24244B1/es unknown
- 2013-09-05 MA MA37888A patent/MA37888B1/fr unknown
- 2013-09-05 IN IN1673DEN2015 patent/IN2015DN01673A/en unknown
- 2013-09-05 BR BR112015004936-2A patent/BR112015004936B1/pt active IP Right Grant
- 2013-09-05 JP JP2015531194A patent/JP6445436B2/ja active Active
- 2013-09-05 CN CN202310406916.6A patent/CN116392598A/zh active Pending
- 2013-09-05 EA EA201590520A patent/EA027685B1/ru not_active IP Right Cessation
- 2013-09-05 EP EP13762967.1A patent/EP2892507B1/en active Active
- 2013-09-05 WO PCT/US2013/058257 patent/WO2014039677A1/en active Application Filing
- 2013-09-05 DK DK13762967.1T patent/DK2892507T3/en active
- 2013-09-05 PE PE2015000289A patent/PE20151005A1/es active IP Right Grant
- 2013-09-05 US US14/018,516 patent/US20140065212A1/en not_active Abandoned
- 2013-09-05 AP AP2015008292A patent/AP2015008292A0/xx unknown
- 2013-09-05 NZ NZ705578A patent/NZ705578A/en unknown
-
2015
- 2015-02-22 IL IL237350A patent/IL237350B/en active IP Right Grant
- 2015-03-02 ZA ZA2015/01394A patent/ZA201501394B/en unknown
- 2015-03-03 PH PH12015500460A patent/PH12015500460B1/en unknown
- 2015-03-04 SA SA515360113A patent/SA515360113B1/ar unknown
- 2015-03-05 GT GT201500053A patent/GT201500053A/es unknown
- 2015-03-05 CR CR20150114A patent/CR20150114A/es unknown
- 2015-03-05 CO CO15050805A patent/CO7310528A2/es unknown
- 2015-03-05 CL CL2015000544A patent/CL2015000544A1/es unknown
-
2016
- 2016-03-01 HK HK16102327.2A patent/HK1214170A1/zh unknown
-
2017
- 2017-04-19 HR HRP20170620TT patent/HRP20170620T1/hr unknown
- 2017-04-21 CY CY20171100450T patent/CY1118839T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE032758T2 (hu) | Regorafenibet tartalmazó bevont gyógyszerészeti készítmény | |
DK1793824T3 (en) | NEW PHARMACEUTICAL COMPOSITIONS COMPRISING 4- (4- (3- (4-chloro-3-trifluoromethylphenyl) ureido) -3-fluoro-phenoxy) -pyridine-2-carboxylic acid to the treatment of hyperproliferative DISORDERS | |
US9737488B2 (en) | Pharmaceutical composition for the treatment of cancer | |
US20230075876A1 (en) | Pharmaceutical composition containing regorafenib and a stabilizing agent | |
JP5700367B2 (ja) | パロキセチン含有フイルムコ−テイング経口製剤 | |
AU2011244932B9 (en) | New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |